Latest Tech News

Aculabs rolls out updates to Online Order web portal tools

The start of 2022 saw Aculabs roll out several new features to our online web portal, including Email Reporting for Result Notification and improved logic used in our Exception Test Flagging feature. The purpose of such functionality is to continue expanding the ways Aculabs communicates with your staff while tackling patient care. Such features

By |2022-10-28T09:34:15-04:00April 21st, 2022|Categories: News|0 Comments

QuantiFERON-TB Gold Plus now performed as in-house testing

Aculabs will be offering QuantiFERON-TB Gold Plus in-house as of April 6, 2022; the test provides highly accurate and reproducible results, single-step testing, and innovative CD8 T cell technology that provides a more comprehensive view of the immune response to TB infection. Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health

By |2023-01-06T17:43:34-05:00April 14th, 2022|Categories: News|0 Comments

Supply Shortage on Grey & Pink Para-Paks to Impact Testing

Please be aware that several send-out tests will be temporarily unavailable to order, as supply shortages impacting the grey and pink parapak kits used for the collection of stool specimen have impacted the reference laboratories in which Aculabs utilizes for such send-out testing. The following are the most commonly ordered tests to be impacted:

By |2022-04-21T15:29:58-04:00March 17th, 2022|Categories: News|0 Comments

New Updates to Aculabs Online Order Entry System

As an industry leader, Aculabs values the way in which our digital and technological systems can always be improved to continually optimize the user experience. Our Online Web Portal remains the main hub for which many clients can 1) most easily place orders and 2) receive order results in the shortest time possible, necessary

By |2022-09-26T10:59:53-04:00January 6th, 2022|Categories: News|0 Comments

FDA Warns of Reduced Sensitivity for Omicron in Rapid Tests

In a new memo, the United States Food & Drug Administration (FDA) has documented and warned both patients and healthcare providers of the risk of Omicron, the latest variant of SARS-CoV-2, displaying reduced sensitivity to rapid antigen tests. Rapid antigen tests, sometimes referred to as lateral flow tests, are often used in occupational and

By |2021-12-29T11:19:27-05:00December 29th, 2021|Categories: News|0 Comments

COVID-19 Vaccine Mandate for HCW on Hold Nationwide

What is the status of the CMS Vaccine Mandate at present? The United States District Court in the Western District of Louisiana has issued a nationwide injunction preventing the federal government from implementing the CMS vaccine mandate for health care staff. This injunction applies to all states which were not covered by the injunction issued yesterday in ten states,

By |2024-01-31T11:08:32-05:00December 1st, 2021|Categories: News|Comments Off on COVID-19 Vaccine Mandate for HCW on Hold Nationwide

As cases soar, a new COVID-19 variant emerges: Omicron

Currently, the B16172 (Delta) variant, the B117 (Alpha) variant, the P1 (Gamma), and B1526 (NY variant) have been reported in New Jersey, but make way for the new one B.1.1.529 also known as Omicron - named for the 15th letter of the greek alphabet. This past Sunday, the WHO said it is not yet clear

By |2024-01-31T10:39:54-05:00November 29th, 2021|Categories: News|Comments Off on As cases soar, a new COVID-19 variant emerges: Omicron

CDC Warns of Supply Shortage for COVID-19 Rapid Tests

In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing

By |2021-10-29T12:54:39-04:00September 2nd, 2021|Categories: News|0 Comments

NJ DOH issues guidance for SARS-CoV-2 positive specimen in cases of vaccine breakthrough and reinfection

The New Jersey Department of Health has asked for all healthcare providers and long-term care facilities in the state to alert them of SARS‐CoV‐2 positive respiratory specimens when vaccine failure is suspected so that genomic sequencing can be performed. Per the guidance: “Because most commercial laboratories retain respiratory specimens only a couple days, once

By |2024-01-31T10:43:10-05:00July 16th, 2021|Categories: News|0 Comments
Go to Top